AMEX Stocks to Watch (GNBT, PSID, APPA, ACTC, MFTH)

Pompano Beach, FL -- (SBWIRE) -- 01/16/2013 -- Csrnewsdaily.com, an investor research portal specializing in several sectors including biotech and healthcare and tech stocks on the U.S. market, issues news updates on the following Tuesday’s Top Gainers:-

Generex Biotechnology Corporation (OTC:GNBT) fell 5.43% and is trading at $0.0331. Generex Biotechnology Corporation is a Canada-based Company, which develops drug delivery systems and technologies for the treatment of diabetes. The Company has developed a proprietary platform technology for the delivery of drugs into the human body through the oral cavity. Its buccal insulin spray product, Generex Oral-lyn is in Phase III clinical trials at several sites around the world.

Can GNBT Continue To Move Higher? Find Out Here

PositiveID Corporation (OTC:PSID) is higher 2.50% and is trading at $0.0205. PositiveID Corporation (PositiveID) is engaged in developing, marketing and selling radio frequency identification (RFID), systems used for the identification of people in the healthcare market. PositiveID is focused on providing health and security identification tools to protect consumers and businesses, operating in two segments: HealthID and ID Security.

Can PSID Extend Rally? Find Out Here

A.P. Pharma, Inc. (OTC:APPA) is lower 1.52% and is trading at $0.650. A.P. Pharma, Inc. operates as pharmaceutical company focused on the development and commercialization of medical treatments utilizing its Biochronomer, a polymer-based drug delivery technology. The Company's focus is on its lead product candidate, APF530, which aims to prevent chemotherapy-induced nausea and vomiting (CINV).

How Should Investors Trade APPA Now? Find Out Here

Advanced Cell Technology, Inc. (OTC:ACTC) added 0.59% and is trading at $0.0855. Advanced Cell Technology, Inc. is a biotechnology company focused on developing and commercializing human embryonic and adult stem cell technology in the emerging field of regenerative medicine. The Company has acquired, developed and maintained a portfolio of patents and patent applications that forms the base for its research and development efforts in the area of embryonic and adult stem cell research.

How Should Investors React To ACTC Now? Find Out Here

Medisafe 1 Technologies Corp (OTC:MFTH) is lower 13.33% and is trading at $0.0026. Develops medical assemblies and protectors. The Company develops medications for medical errors and drug related injury.

How Should Investors React To MFTH Now? Find Out Here

About Csrnewsdaily.com
Csrnewsdaily.com has a finger on the pulse of many sectors including renewable energy, oil, pharma, mining, finance, and healthcare. Our in depth research and analysis of NASDAQ, OTCBB, Pink Sheets, and NYSE has yielded considerable gains for our subscribers.

Our to-the-minute reports and alerts coupled with breaking news, analysis, investment strategies, and FREE subscription email services contribute to our role as one of the leading investor relations marketing firms.

Disclaimer
The assembled information disseminated by Csrnewsdaily.com is for information purposes only, and is neither a solicitation to buy nor an offer to sell securities. Csrnewsdaily.com does expect that investors will buy and sell securities based on information assembled and presented in phd-trading.com. PLEASE always do your own due diligence, and consult your financial advisor.

Contact:
Csrnewsdaily.com
info@csrnewsdaily.com